(Reuters) - The pharmaceutical company lost $68.7 million, or 92 cents
a share for the period ended June 30, compared with a profit
$7.5 million, or 8 cents a share for the same quarter a year
earlier.
Read more at Reuters.com Market News
a share for the period ended June 30, compared with a profit
$7.5 million, or 8 cents a share for the same quarter a year
earlier.
Read more at Reuters.com Market News
No comments:
Post a Comment